Haihe Biopharma Co., Ltd.

This study tests a drug called CYH33 in people with rare conditions that cause abnormal tissue growth and blood vessel problems. The goal is to see if the drug can safely shrink overgrown tissue and control the disease. About 141 adults and teens aged 12 and older will take part.

This study tests an experimental drug called HH2853 in people with certain blood cancers (non-Hodgkin's lymphomas) or advanced solid tumors that have not responded to standard treatments. The goal is to find a safe dose and see if the drug can shrink tumors. About 254 adults will…

This study tests an experimental oral drug called HH2853 in people with peripheral T-cell lymphoma that has come back or not responded to standard treatments. The drug works by blocking certain proteins that help cancer cells grow. About 100 participants will take the pill daily …